Fennec Pharmaceuticals Files 8-K on Financials
Ticker: FENC · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1211583
| Field | Detail |
|---|---|
| Company | Fennec Pharmaceuticals Inc. (FENC) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
Related Tickers: FENC
TL;DR
FENNEC PHARMACEUTICALS (FENC) FILED AN 8-K ON 3/10/25 DETAILING FINANCIALS.
AI Summary
Fennec Pharmaceuticals Inc. filed an 8-K on March 10, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the report being as of March 10, 2025. The company, previously known as Adherex Technologies Inc., is incorporated in British Columbia, Canada.
Why It Matters
This 8-K filing provides an update on Fennec Pharmaceuticals' financial status and operational results, which is crucial information for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Fennec Pharmaceuticals Inc. (company) — Registrant
- Adherex Technologies Inc (company) — Former company name
- March 10, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Fennec Pharmaceuticals Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was this report filed?
This report was filed on March 10, 2025.
What was Fennec Pharmaceuticals Inc. previously known as?
Fennec Pharmaceuticals Inc. was previously known as Adherex Technologies Inc.
Where is Fennec Pharmaceuticals Inc. incorporated?
Fennec Pharmaceuticals Inc. is incorporated in British Columbia, Canada.
What is the SIC code for Fennec Pharmaceuticals Inc.?
The Standard Industrial Classification (SIC) code for Fennec Pharmaceuticals Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding FENNEC PHARMACEUTICALS INC. (FENC).